Pedro M. Enríquez‐Navas

Generating author description...

All published works

Action	Title	Year	Authors
+	Data from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 6 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 4 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Data from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 3 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 1 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Supplementary Figures from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 1 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 4 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 5 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 6 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Supplementary Figures from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 5 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 3 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 2 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Movie 2 from Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2023	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Data from Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution	2023	Arig Ibrahim‐Hashim Mark Robertson‐Tessi Pedro M. Enríquez‐Navas Mehdi Damaghi Yoganand Balagurunathan Jonathan W. Wojtkowiak Shonagh Russell Yoonseok Kam Mark C. Lloyd Marilyn M. Bui
+	Data from Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution	2023	Arig Ibrahim‐Hashim Mark Robertson‐Tessi Pedro M. Enríquez‐Navas Mehdi Damaghi Yoganand Balagurunathan Jonathan W. Wojtkowiak Shonagh Russell Yoonseok Kam Mark C. Lloyd Marilyn M. Bui
+	Supplemental Movie from Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution	2023	Arig Ibrahim‐Hashim Mark Robertson‐Tessi Pedro M. Enríquez‐Navas Mehdi Damaghi Yoganand Balagurunathan Jonathan W. Wojtkowiak Shonagh Russell Yoonseok Kam Mark C. Lloyd Marilyn M. Bui
+	Supplemental Movie from Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution	2023	Arig Ibrahim‐Hashim Mark Robertson‐Tessi Pedro M. Enríquez‐Navas Mehdi Damaghi Yoganand Balagurunathan Jonathan W. Wojtkowiak Shonagh Russell Yoonseok Kam Mark C. Lloyd Marilyn M. Bui
+	Evolutionary strategies to overcome cancer cell resistance to treatment	2020	Pedro M. Enríquez‐Navas Robert A. Gatenby
+ PDF Chat	Harnessing patient-specific response dynamics to optimize evolutionary therapies for metastatic clear cell renal cell carcinoma – Learning to adapt	2019	Inmaculada C. Sorribes Amrita Basu Renee Brady‐Nicholls Pedro M. Enríquez‐Navas Xu Feng Jakob Nikolas Kather Niveditha Nerlakanti RJ Stephens Maximilian Strobl Iman Tavassoly
+	Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2018	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+ PDF Chat	Adaptive vs continuous cancer therapy: Exploiting space and trade-offs in drug scheduling	2017	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+ PDF Chat	Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies	2017	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+ PDF Chat	Adaptive Therapy For Heterogeneous Cancer: Exploiting Space And Trade-Offs In Drug Scheduling	2017	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution	2017	Arig Ibrahim‐Hashim Mark Robertson‐Tessi Pedro M. Enríquez‐Navas Mehdi Damaghi Yoganand Balagurunathan Jonathan W. Wojtkowiak Shonagh Russell Yoonseok Kam Mark C. Lloyd Marilyn M. Bui
+	Applying Tools From Evolutionary Biology to Cancer Research	2017	Pedro M. Enríquez‐Navas Robert A. Gatenby
+	Abstract B11: Adaptive therapy modifies tumor vascularity	2015	Pedro M. Enríquez‐Navas Jonathan W. Wojtkowiak Epi Ruiz Sabrina Hassan Robert J. Gillies Robert A. Gatenby
+ PDF Chat	Application of Evolutionary Principles to Cancer Therapy	2015	Pedro M. Enríquez‐Navas Jonathan W. Wojtkowiak Robert A. Gatenby

Common Coauthors

Coauthor	Papers Together
Robert A. Gatenby	29
Alexander R.A. Anderson	25
Jill Gallaher	20
Kimberly A. Luddy	20
Jonathan W. Wojtkowiak	7
Robert J. Gillies	6
Yoganand Balagurunathan	5
Marilyn M. Bui	5
Mark Robertson‐Tessi	5
Arig Ibrahim‐Hashim	5
Shonagh Russell	5
Yoonseok Kam	5
Mark C. Lloyd	5
Mehdi Damaghi	5
Joel S. Brown	4
Joel S. Brown	1
Xu Feng	1
RJ Stephens	1
Brandon J. Manley	1
Noemi Vitos	1
Renee Brady‐Nicholls	1
Heiko Enderling	1
Iman Tavassoly	1
Sabrina Hassan	1
Niveditha Nerlakanti	1
Dawn Lemanne	1
Maximilian Strobl	1
Epi Ruiz	1
Amrita Basu	1
Inmaculada C. Sorribes	1
Jakob Nikolas Kather	1
Cliona O’Farrelly	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Evolutionary Approaches to Prolong Progression-Free Survival in Breast Cancer	2012	Ariosto S. Silva Yoonseok Kam Zayar P. Khin Susan Minton Robert J. Gillies Robert A. Gatenby	5
+ PDF Chat	Computational Modeling of 3D Tumor Growth and Angiogenesis for Chemotherapy Evaluation	2014	Lei Tang Anne L. van de Ven Dongmin Guo Vivi Andasari Vittorio Cristini King C. Li Xiaobo Zhou	3
+ PDF Chat	Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates	2016	Xiaoqiang Sun Jiguang Bao Yongzhao Shao	3
+	Adaptive Therapy	2009	Robert A. Gatenby Ariosto S. Silva Robert J. Gillies B. Roy Frieden	3
+ PDF Chat	Spatial Heterogeneity in Drug Concentrations Can Facilitate the Emergence of Resistance to Cancer Therapy	2015	Feng Fu Martin A. Nowak Sebastian Bonhoeffer	3
+ PDF Chat	Mathematical and computational models of drug transport in tumours	2014	Christian Groh M.E. Hubbard Pamela F. Jones Paul M. Loadman N. Periasamy B. D. Sleeman S W Smye Chris Twelves Roger M. Phillips	3
+ PDF Chat	Evolution of intratumoral phenotypic heterogeneity: the role of trait inheritance	2013	Jill Gallaher Alexander R.A. Anderson	3
+ PDF Chat	Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases	2016	Ami Shah Katarzyna A. Rejniak Jana L. Gevertz	2
+	Integrative mathematical oncology	2008	Alexander R.A. Anderson Vito Quaranta	2
+ PDF Chat	Current Advances in Mathematical Modeling of Anti-Cancer Drug Penetration into Tumor Tissues	2013	MunJu Kim Robert J. Gillies Katarzyna A. Rejniak	2
+ PDF Chat	Cancer Prevention Strategies That Address the Evolutionary Dynamics of Neoplastic Cells: Simulating Benign Cell Boosters and Selection for Chemosensitivity	2004	Carlo C. Maley Brian J. Reid Stephanie Forrest	2
+	Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes	2015	Mark Robertson‐Tessi Robert J. Gillies Robert A. Gatenby Alexander R.A. Anderson	2
+	Evolutionary dynamics of carcinogenesis and why targeted therapy does not work	2012	Robert J. Gillies Daniel Verduzco Robert A. Gatenby	2
+ PDF Chat	The biology underlying molecular imaging in oncology: from genome to anatome and back again	2010	Robert J. Gillies Alexander R.A. Anderson Robert A. Gatenby David L. Morse	2
+ PDF Chat	Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces	2016	Mark C. Lloyd Jessica J. Cunningham Marilyn M. Bui Robert J. Gillies Joel S. Brown Robert A. Gatenby	1
+ PDF Chat	How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient	2017	Elsa Hansen Robert J. Woods Andrew F. Read	1
+ PDF Chat	Role of vascular normalization in benefit from metronomic chemotherapy	2017	Fotios Mpekris James W. Baish Triantafyllos Stylianopoulos Rakesh K. Jain	1
+ PDF Chat	Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow	2018	Robert J. Gillies Joel S. Brown Alexander R.A. Anderson Robert A. Gatenby	1
+ PDF Chat	Optimizing Cancer Treatment Using Game Theory	2018	Kateřina Staňková Joel S. Brown William S. Dalton Robert A. Gatenby	1
+ PDF Chat	Multidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy	2019	Jeffrey West Mina N. Dinh Joel S. Brown Jingsong Zhang Alexander R.A. Anderson Robert A. Gatenby	1
+	Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2018	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson	1
+ PDF Chat	Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers	2013	Sébastien Benzekry Philip Hahnfeldt	1
+ PDF Chat	A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity	2015	Bartłomiej Wacław Ivana Božić Meredith E. Pittman Ralph H. Hruban Bert Vogelstein Martin A. Nowak	1
+ PDF Chat	Exploiting Evolution To Treat Drug Resistance: Combination Therapy and the Double Bind	2012	David Basanta Robert A. Gatenby Alexander R.A. Anderson	1
+	Turning ecology and evolution against cancer	2014	Kirill S. Korolev João B. Xavier Jeff Gore	1
+ PDF Chat	Hybrid models of tumor growth	2010	Katarzyna A. Rejniak Alexander R.A. Anderson	1
+	A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion	2005	Alexander R.A. Anderson	1
+ PDF Chat	Impact of deleterious passenger mutations on cancer progression	2013	Christopher D. McFarland Kirill S. Korolev Gregory V. Kryukov Shamil Sunyaev Leonid A. Mirny	1
+	Mathematical analysis and simulations involving chemotherapy and surgeryon large human tumours under a suitable cell-kill functional response	2012	Diego Samuel Rodrigues Paulo Fernando de Arruda Mancera	1
+ PDF Chat	The Role of Tumor Tissue Architecture in Treatment Penetration and Efficacy: An Integrative Study	2013	Katarzyna A. Rejniak Verónica Estrella Tingan Chen Allison S. Cohen Mark C. Lloyd David L. Morse	1
+	Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment	2006	Alexander R.A. Anderson Alissa M. Weaver Peter T. Cummings Vito Quaranta	1
+	Cancer as an evolutionary and ecological process	2006	Lauren M.F. Merlo John W. Pepper Brian J. Reid Carlo C. Maley	1
+ PDF Chat	Evolutionary Dynamics in Cancer Therapy	2011	Jessica J. Cunningham Robert A. Gatenby Joel S. Brown	1
+ PDF Chat	Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis	1994	Vladimir A. Kuznetsov Iliya A. Makalkin Mark A. Taylor Alan S. Perelson	1
+ PDF Chat	Intratumor Heterogeneity in Evolutionary Models of Tumor Progression	2011	Rick Durrett Jasmine Foo Kevin Leder John Mayberry Franziska Michor	1
+	Limiting the Development of Anti-Cancer Drug Resistance in a Spatial Model of Micrometastases	2016	Ami Shah Katarzyna A. Rejniak Jana L. Gevertz	1